Needham & Company Starts NuVasive (NUVA) at Buy, $28 PT
Tweet Send to a Friend
Needham & Company initiates coverage on NuVasive (NASDAQ: NUVA) with a Buy. PT $28.00.
Analyst Mike Matson comments, "NUVA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst Mike Matson comments, "NUVA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
